Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
for
Pancreatic Cancer
Location: Milwaukee WI, Scottsdale AZ
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04683315
Phase2, Recruiting
Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
for
Myeloproliferative Neoplasms
Location: Milwaukee WI, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06291987
Phase1, Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for
Neuroendocrine Tumors Unresectable,
Location: Milwaukee WI, Chicago IL, Grand Rapids MI, Iowa City IA,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05636618
Phase1, Phase2, Recruiting
SynCardia 70cc TAH-t for Destination Therapy (DT)
for
Life-threatening, Biventricular Heart Failure,
Location: Milwaukee WI, Richmond VA, Oklahoma City OK, Houston TX,
Sponsor: SynCardia Systems. LLC
Sex: All
Age: 19+
Code: NCT02232659
Recruiting
Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis
for
Light Chain (AL) Amyloidosis
Location: Milwaukee WI, Detroit MI, Boston MA, Duarte CA
Sponsor: Sorrento Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04316442
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas
for
Vestibular Schwannoma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT05702749
Recruiting
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
for
Pancreas Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06228599
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for
Prostate Cancer,
Location: Milwaukee WI, Madison WI, Chicago IL, Rochester MN,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18 - 70+
Code: NCT05519449
Phase1, Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Milwaukee WI, Arlington Heights IL, Madison WI,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
for
Chronic Phase Chronic Myelogenous Leukemia
Location: Milwaukee WI, Detroit MI, Buffalo NY, New York NY,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04838041
Phase2, Recruiting
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
for
Rectal Adenocarcinoma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04808323
Phase1, Recruiting
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
for
Pancreatic Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT03322995
Phase2, Recruiting
Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors
for
Hematopoietic and Lymphoid Cell Neoplasm
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04892823
Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for
Cholangiocarcinoma
Location: Milwaukee WI, Chicago IL, Charlottesville VA,
Sponsor: Genfit
Sex: All
Age: 18+
Code: NCT05874414
Phase1, Phase2, Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)